Cargando…

The Emerging Roles of RNA Modifications in Glioblastoma

Glioblastoma (GBM) is a grade IV glioma that is the most malignant brain tumor type. Currently, there are no effective and sufficient therapeutic strategies for its treatment because its pathological mechanism is not fully characterized. With the fast development of the Next Generation Sequencing (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Zhen, Cui, Hongjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140112/ https://www.ncbi.nlm.nih.gov/pubmed/32244981 http://dx.doi.org/10.3390/cancers12030736

Ejemplares similares

The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors
por: Dong, Zhen, et al.
Publicado: (2018)

Mitoepigenetics and Its Emerging Roles in Cancer
por: Dong, Zhen, et al.
Publicado: (2020)

Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma
por: Dome, Anton, et al.
Publicado: (2022)

The emerging role of RNA modifications in the regulation of mRNA stability
por: Boo, Sung Ho, et al.
Publicado: (2020)

Overcoming TRAIL Resistance for Glioblastoma Treatment
por: Deng, Longfei, et al.
Publicado: (2021)

Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
por: Wan, Sicheng, et al.
Publicado: (2023)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
por: Xu, Xiaoxin, et al.
Publicado: (2023)

Emerging role of RNA modification N6-methyladenosine in immune evasion
por: Lou, Xin, et al.
Publicado: (2021)

Emerging roles of m6A RNA modification in cancer therapeutic resistance
por: Liu, Wei-Wei, et al.
Publicado: (2023)

The Roles and Regulation of m(6)A Modification in Glioblastoma Stem Cells and Tumorigenesis
por: Li, Peng, et al.
Publicado: (2022)

Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
por: Sikorski, Vilbert, et al.
Publicado: (2022)

The dynamic RNA modification 5‐methylcytosine and its emerging role as an epitranscriptomic mark
por: Trixl, Lukas, et al.
Publicado: (2018)

Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases
por: Wilkinson, Emma, et al.
Publicado: (2021)

RNA modification patterns based on major RNA modifications define tumor microenvironment characteristics in glioblastoma
por: Li, Ganglei, et al.
Publicado: (2022)

The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma
por: Shi, Pengfei, et al.
Publicado: (2023)

Emerging roles of histone modifications and HDACs in RNA splicing
por: Rahhal, Raneen, et al.
Publicado: (2019)

Regulation of RNA N(6)-methyladenosine modification and its emerging roles in skeletal muscle development
por: Li, Jiju, et al.
Publicado: (2021)

Emerging Biomarkers in Glioblastoma
por: McNamara, Mairéad G., et al.
Publicado: (2013)

Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma
por: DeOcesano-Pereira, Carlos, et al.
Publicado: (2020)

The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
por: Wu, Qiong, et al.
Publicado: (2021)

Roles of the m(6)A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses
por: Yuan, Feng, et al.
Publicado: (2022)

The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity
por: Tong, Jie, et al.
Publicado: (2022)

The Role of RNA Modification in HIV-1 Infection
por: Wang, Shuqi, et al.
Publicado: (2022)

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
por: Lee, Jin-Ku, et al.
Publicado: (2014)

Emerging Biomarkers for Immunotherapy in Glioblastoma
por: Mensali, Nadia, et al.
Publicado: (2022)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

Emerging Roles of Post-Translational Modifications in Nucleotide Excision Repair
por: Borsos, Barbara N., et al.
Publicado: (2020)

The emerging roles of m(6)A modification in liver carcinogenesis
por: Pan, Xue-yin, et al.
Publicado: (2021)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

The Emerging Role of m6A Modification in Endocrine Cancer
por: Ji, Xiaoyu, et al.
Publicado: (2023)

The emerging roles of MAPK-AMPK in ferroptosis regulatory network
por: Wang, Xinyue, et al.
Publicado: (2023)

MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells
por: Dong, Zhen, et al.
Publicado: (2019)

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
por: Kirstein, Anna, et al.
Publicado: (2020)

Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer
por: Zhang, Xiaolin, et al.
Publicado: (2021)

The Emerging Role of RNA Modifications in DNA Double-Strand Break Repair
por: Jimeno, Sonia, et al.
Publicado: (2021)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators as a Therapy for Glioblastoma
por: Nadeem Abbas, Muhammad, et al.
Publicado: (2019)

Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway
por: Shelton, Samantha B., et al.
Publicado: (2016)

Roles of RNA Modifications in Diverse Cellular Functions
por: Wilkinson, Emma, et al.
Publicado: (2022)

Insights into the regulatory role of RNA methylation modifications in glioma
por: Long, Shengrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jroaufodkef7g8h5j7uefvc9k6